Researcher profile
SIMONE BERTINI
Public evidence
5 connected articles
Recent Progress in the Development of Selective MAGL Modulators (2020-2026).2026 · PubMed Central Open AccessMethods for Assessing MAGL Enzymatic Activity: An Extensive Review of Past and Emerging Approaches.2025 · Europe PMCNovel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1<i>H</i>)-One Scaffold.2022 · Europe PMCPositive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist.2020 · Europe PMCTraditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.2018 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.